Circular RNA Cdr1as Upregulates SCAI to Suppress Cisplatin Resistance in Ovarian Cancer via miR-1270 Suppression.

Mol Ther Nucleic Acids · 2019 · PMC6726918 · PMID 31479922

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

As shown in Figure 1 C, there was a decreasing trend in Cdr1as levels from normal ovarian tissues to cisplatin-sensitive ovarian cancer tissues and then to cisplatin-resistant ovarian cancer tissues, and the differences among the three groups were significant (p < 0.001).

also in 47,180 other papers

an increasing trendno p-value reported

As shown in Figure 5 A, there was an increasing trend in miR-1270 levels from normal ovarian tissues to cisplatin-sensitive ovarian cancer tissues and then to cisplatin-resistant ovarian cancer tissues, and the differences among the three groups were significant (p < 0.01).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.